The potential for new HHS leadership

Omar Ishrak, Medtronic chairman and CEO—"Improve outcomes and lower costs—that’s what value-based healthcare is. I know there is overall support for that notion. The journey toward value-based healthcare is not going to change, no matter who the administration is. There is no other alternative. I think there is general agreement around that. The question is, how do you get there? We think that some of the programs that have been put in place by CMS are ones that will probably stay in some form. I think the CJR will almost certainly stay and...

January 17th, 2017
0
The potential for corporate tax reform and repatriation

Karen Parkhill, Medtronic CFO—"We would say that the Republican blueprint, as written right now, is a slight benefit for Medtronic if the details remain similar to what is written on the high level. There are puts and takes in the tax reform. The benefit of repatriation would be the largest benefit for us.

On the repatriation side, it is our assumption that there will be an impact on both accumulated foreign earnings and on cash currently overseas. We have...

January 17th, 2017
0
The potential for market impact from uncertainty around ACA "repeal and replace"

Omar Ishrak, Medtronic chairman and CEO—“To the degree that we can tell, we haven’t really seen anything dramatic. This thing is pretty steady, the U.S. market is holding. We think that our new product introduction cycles in the U.S. especially have a bigger impact on our growth rates at this stage than the markets themselves. The markets are pretty steady . . .”

Alex Gorsky, Johnson & Johnson chairman and CEO—“We haven’t seen a significant increase in hospital volumes . . . I think...

January 17th, 2017
0

Medical device executives look ahead to the changes expected to come out of Washington, DC this year. Here's how they see issues like the medical device tax, repatriation, and agency leadership impacting their companies.

2017 is set to be a year of upheaval. The Trump administration and the new Congress are expected to usher in legislative changes while unwinding current policies. This of course is likely to mean big changes for the healthcare industry.

One move anticipated by many industry onlookers is a permanent repeal of the medical device excise tax. According to recently...

January 17th, 2017
0

If you’re heading to Anaheim, CA, for the world's largest annual medtech expo and conference February 7–9, 2017, be sure to check out these goings-on at the event.

Jamie Hartford

Next month, medical device professionals from across the country will converge in sunny Southern California to attend Medical Design & Manufacturing (MD&M) West, the world’s largest annual medtech event.

For more than three decades, the MD&M West expo and conference has united the industry’s top innovators with cutting-edge suppliers and forward-thinking influencers to help speed their medical device products to market. This year’s event will bring together more than 20,000 engineers and executives for three days of networking and...

January 13th, 2017
0

Johnson & Johnson Medical Devices Companies recently announced the launch of CareAdvantage, its answer to the value-based care environment. A top JNJ executive explains why he thinks the company’s offering has an edge.

Marie Thibault

Johnson & Johnson Medical Devices Companies (JJMDC) is jumping feet first into the value-based care environment with its new CareAdvantage offering. The broad program, announced on January 9, aims to help hospital customers achieve the ultimate goal of value-based care: improving outcomes, increasing patient satisfaction, and reducing the cost of care.

According to ...

January 13th, 2017
0

Here are five ways to innovate and re-engineer sales and marketing that can help medical device companies become more nimble competitors against low-cost players.

Robert Boyce

The medical device industry is being forced to change, and change fast. The reason: the high cost of sales and marketing. In established medical device companies, sales and marketing accounts for about one third of the cost of a device, about double of what is found in other mature industries.

The business model was built decades ago when the sales rep was the preeminent expert that the surgeon leaned on to learn about the technical and clinical uses of a device. Reps created deep personal relationships with physicians and were by their side in the operating room. At a time when...

January 13th, 2017
0

Here's how middleware’s capabilities can move medical devices from charting to active patient monitoring and intervention.

John Zaleski, PhD, CAP, CPHIMS

Historically, medical device data has been isolated, trapped in silos, each having unique communication protocols, physical connections, update rates, and terminology, but key advances have put medical devices on the precipice of an evolutionary leap from charting and documentation to active patient monitoring and intervention.

Tracked through multivariate, temporally trended information, clinicians can apply historical and real-time data to facilitate real-time clinical decision-making that is based upon changing and evolving trends.

...
January 12th, 2017
0

The first installment in a series on women in medtech focuses on Marlou Janssen’s impressive career and outstanding results at Biotronik.

Maria Shepherd

Who better to ask about how to increase the number of women executives in the medical device industry than Marlou Janssen? Janssen is president of Biotronik, Inc., and is one of the most prominent women in medtech.

The accelerated track of Janssen’s career is impressive. She started at Medtronic but moved to Biotronik in 2001. At  Biotronik, she rose rapidly through the ranks to global vice president, Cardiac Rhythm Management. After a short stint at St Jude...

January 10th, 2017
0

A new list breaks down ten recent medical innovations and gives executives practical steps to determine whether the technology is right for their hospital.

Marie Thibault

The capabilities of today’s medical technology offerings may seem ever-expanding, but unfortunately hospital budgets have a firm limit. That leaves hospital executives with the dilemma of trying to determine which new medical products are the best investment for their facilities.

A number of factors can play a role in hospital purchasing decisions—budgets, priority areas of therapy, competition from other neighboring facilities, and long-term visions. A new report from the ECRI Institute, “2017 Top 10...

January 9th, 2017
0